Abstract
Twenty-four healthy male subjects participated in a study comparing plasma concentrations of nitroglycerin generated by single applications of Nitradisc 32 mg, Transiderm-Nitro 50 mg and Nitro-Dur 104 mg patches and from one inch of Nitrobid 2% ointment. The three patch preparations are designed to release 10 mg nitroglycerin systemically over a 24 h period. Nitrobid ointment is intended to deliver 15 mg nitroglycerin per inch of ointment, and to be reapplied at least every 8 h. Blood was taken for nitroglycerin assay up to and including 24 h after each application. Assay for nitroglycerin was performed using a gas chromatography-mass spectrometry technique. Plasma concentrations of nitroglycerin were sustained up to the 24 h mark with all three patch preparations, but not with application of Nitrobid ointment. Nitrobid was associated with a rapid rise in nitroglycerin plasma concentrations maximal 1 h after application. Plasma concentrations of nitroglycerin absorbed from Nitrobid ointment fell below those absorbed from all three patch preparations after 8 h. Clinically, all four formulations were similar with respect to side effects, with headache and dizziness being the most common.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong P. W., Armstrong J. A., Marks G. S. Blood levels after sublingual nitroglycerin. Circulation. 1979 Mar;59(3):585–588. doi: 10.1161/01.cir.59.3.585. [DOI] [PubMed] [Google Scholar]
- Bogaert M. G. Clinical pharmacokinetics of organic nitrates. Clin Pharmacokinet. 1983 Sep-Oct;8(5):410–421. doi: 10.2165/00003088-198308050-00003. [DOI] [PubMed] [Google Scholar]
- Cote D. D., Torchia M. G. Nitroglycerin adsorption to polyvinylchloride seriously interferes with its clinical use. Anesth Analg. 1982 Jun;61(6):541–543. [PubMed] [Google Scholar]
- Curry S. H., Kwon H. R., Perrin J. H., Culp J. R., Pepine C. J., Yu W. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet. 1984 Jun 9;1(8389):1297–1297. doi: 10.1016/s0140-6736(84)92476-0. [DOI] [PubMed] [Google Scholar]
- Gielsdorf W., Schlegel E., Settlage J. A., Jaeger H., Fink E. Bioverfügbarkeit von Glyceroltrinitrat (Nitroglycerin) aus einer Salbenzubereitung. Arzneimittelforschung. 1983;33(12):1677–1679. [PubMed] [Google Scholar]
- Kala R., Hirvonen P., Gordin A., Sundberg S., Auvinen J., Halonen P. I. Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand. 1983;213(3):165–170. doi: 10.1111/j.0954-6820.1983.tb03711.x. [DOI] [PubMed] [Google Scholar]
- Meister S. G., Engel T. R., Guiha N., Furr C. M., Feitosa G. S., Hart K., Frankl W. S. Sustained haemodynamic action of nitroglycerin ointment. Br Heart J. 1976 Oct;38(10):1031–1036. doi: 10.1136/hrt.38.10.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parke J. D., Higgins S. E. Hazards associated with chest application of nitroglycerin ointments. JAMA. 1982 Jul 23;248(4):427–427. [PubMed] [Google Scholar]
- Sved S., McLean W. M., McGilveray I. J. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans. J Pharm Sci. 1981 Dec;70(12):1368–1369. doi: 10.1002/jps.2600701220. [DOI] [PubMed] [Google Scholar]
- Yliruusi J. K., Sothmann A. G., Laine R. H., Rajasilta R. A., Kristoffersson E. R. Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers. Am J Hosp Pharm. 1982 Jun;39(6):1018–1021. [PubMed] [Google Scholar]